See more : Metalpha Technology Holding Limited (LYL) Income Statement Analysis – Financial Results
Complete financial analysis of China Eastern Airlines Corporation Limited (CEA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Eastern Airlines Corporation Limited, a leading company in the Airlines, Airports & Air Services industry within the Industrials sector.
- WELLYSUN INC (6988.TW) Income Statement Analysis – Financial Results
- Anglo American plc (AAM.SW) Income Statement Analysis – Financial Results
- Mirza International Limited (MIRZAINT.BO) Income Statement Analysis – Financial Results
- Vifor Pharma AG (GNHAY) Income Statement Analysis – Financial Results
- GVK Power & Infrastructure Limited (GVKPIL.NS) Income Statement Analysis – Financial Results
China Eastern Airlines Corporation Limited (CEA)
About China Eastern Airlines Corporation Limited
China Eastern Airlines Corporation Limited, together with its subsidiaries, operates in the civil aviation industry in the People's Republic of China, Hong Kong, Macau, Taiwan, and internationally. The company offers passenger, cargo, mail delivery, ground, tour operations, air catering, and other miscellaneous services. It is also involved in flight training; airline maintenance; the provision of import and export, investment, leasing, and consultation services; the research and development of technology and products in the field of aviation; and e-commerce platform and ticket agent services. As of December 31, 2021, the company operated a fleet of 758 aircraft, including 752 passenger aircraft and 6 business aircraft. China Eastern Airlines Corporation Limited was founded in 1988 and is headquartered in Shanghai, the People's Republic of China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 113.74B | 46.11B | 66.89B | 58.47B | 120.80B | 115.21B | 102.48B | 98.90B | 93.97B | 90.19B | 88.25B | 85.25B | 83.46B | 74.46B | 40.28B | 41.74B | 42.52B | 37.49B | 27.45B | 21.04B | 14.28B | 13.08B | 12.15B | 11.22B | 10.16B | 8.17B | 8.54B | 7.39B | 6.62B | 6.07B |
Cost of Revenue | 112.46B | 74.60B | 81.83B | 72.52B | 108.87B | 103.48B | 91.59B | 82.68B | 77.24B | 78.74B | 80.46B | 70.07B | 48.63B | 39.85B | 24.86B | 31.47B | 15.12B | 13.61B | 15.14B | 11.57B | 7.74B | 6.15B | 5.84B | 6.15B | 5.10B | 4.10B | 3.46B | 5.10B | 4.46B | 3.78B |
Gross Profit | 1.28B | -28.49B | -14.94B | -14.05B | 11.93B | 11.73B | 10.88B | 16.23B | 16.73B | 11.44B | 7.78B | 15.18B | 34.84B | 34.61B | 15.42B | 10.28B | 27.40B | 23.88B | 12.32B | 9.47B | 6.54B | 6.93B | 6.31B | 5.07B | 5.07B | 4.08B | 5.09B | 2.29B | 2.16B | 2.28B |
Gross Profit Ratio | 1.13% | -61.78% | -22.34% | -24.03% | 9.88% | 10.18% | 10.62% | 16.41% | 17.81% | 12.69% | 8.82% | 17.81% | 41.74% | 46.49% | 38.28% | 24.62% | 64.45% | 63.70% | 44.87% | 45.02% | 45.79% | 52.99% | 51.95% | 45.16% | 49.85% | 49.88% | 59.55% | 31.00% | 32.63% | 37.64% |
Research & Development | 277.00M | 305.00M | 315.00M | 176.00M | 160.00M | 135.00M | 92.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 670.00M | 680.00M | 695.00M | 799.00M | 863.00M | 741.00M | 667.00M | 586.00M | 977.00M | 1.04B | 915.48M | 8.98B | 19.41B | 19.26B | 10.08B | 9.64B | 3.94B | 2.13B | 1.30B | 1.18B | 1.08B | 829.93M | 642.71M | 509.63M | 428.79M | 315.80M | 301.99M | 240.07M | 235.82M | 164.54M |
Selling & Marketing | 3.12B | 2.25B | 1.13B | 1.57B | 4.13B | 3.81B | 3.29B | 3.13B | 3.65B | 4.12B | 4.14B | 3.73B | 3.74B | 3.32B | 1.98B | 1.56B | 1.81B | 1.32B | 1.95B | 1.45B | 1.10B | 1.12B | 1.30B | 1.35B | 1.05B | 1.00B | 1.04B | 826.33M | 772.26M | 701.96M |
SG&A | 7.25B | 2.93B | 1.13B | 1.57B | 4.13B | 3.81B | 3.29B | 3.13B | 3.65B | 4.12B | 4.14B | 12.71B | 23.15B | 22.59B | 12.06B | 11.20B | 5.75B | 3.45B | 2.36B | 1.87B | 1.45B | 1.04B | 849.22M | 2.67B | 2.43B | 2.41B | 2.38B | 1.07B | 1.01B | 866.50M |
Other Expenses | 1.63B | -10.00M | -1.49B | -1.70B | -1.94B | 68.00M | 1.37B | 5.67B | 5.48B | 4.60B | 3.30B | 2.73B | 1.58B | 933.44M | 1.60B | 868.40M | 633.23M | 529.09M | 1.02B | 1.02B | 592.19M | 601.72M | 526.88M | 618.60M | 954.57M | 257.77M | 266.11M | 147.51M | 288.44M | 243.44M |
Operating Expenses | 9.80B | 3.16B | -360.00M | -125.00M | 2.19B | 2.97B | 2.53B | 4.01B | 4.33B | 5.44B | 6.39B | 10.99B | 30.03B | 28.51B | 13.49B | 22.39B | 27.84B | 27.30B | 27.69B | 19.71B | 14.06B | 12.07B | 11.28B | 4.29B | 4.05B | 3.90B | 3.65B | 1.27B | 1.15B | 1.01B |
Cost & Expenses | 122.29B | 77.76B | 81.47B | 72.40B | 111.06B | 106.44B | 94.12B | 86.69B | 81.57B | 84.18B | 86.86B | 81.06B | 78.65B | 68.36B | 38.35B | 53.85B | 42.96B | 40.90B | 42.82B | 31.28B | 21.80B | 18.22B | 17.12B | 10.44B | 9.14B | 8.00B | 7.10B | 6.37B | 5.62B | 4.80B |
Interest Income | 495.00M | 494.00M | 339.00M | 166.00M | 96.00M | 110.00M | 111.00M | 96.00M | 66.00M | 88.00M | 148.11M | 200.77M | 2.02B | 1.16B | 205.30M | 2.06B | 96.85M | 120.16M | 149.98M | 128.74M | 108.41M | 77.33M | 78.97M | 131.19M | 0.00 | -201.30M | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.76B | 6.13B | 5.81B | 5.21B | 5.17B | 3.58B | 3.18B | 2.70B | 2.19B | 1.96B | 1.55B | 1.70B | 1.46B | 1.50B | 1.75B | 2.33B | 1.95B | 1.73B | 1.25B | 815.40M | 822.47M | 884.50M | 916.16M | 1.00B | 0.00 | 852.84M | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 24.29B | 21.81B | 22.72B | 22.24B | 22.08B | 15.28B | 13.95B | 12.50B | 10.86B | 9.18B | 8.23B | 7.56B | 6.97B | 6.76B | 5.20B | 4.76B | 4.81B | -4.58B | -3.94B | 2.30B | 1.99B | 1.73B | 1.72B | -1.62B | -1.61B | -1.49B | -1.26B | 560.25M | 331.91M | 710.17M |
EBITDA | 18.77B | -16.19B | 7.51B | 11.13B | 31.54B | 22.92B | 25.69B | 21.77B | 18.33B | 6.22B | 1.60B | 4.52B | 13.60B | 14.01B | 7.53B | -7.04B | 4.51B | 2.93B | 4.40B | 3.59B | 1.92B | 2.45B | 2.69B | 2.06B | 2.36B | 1.90B | 947.59M | 1.02B | 1.01B | 1.27B |
EBITDA Ratio | 16.50% | -28.13% | 11.89% | -23.26% | 26.38% | 7.94% | 8.51% | 25.33% | 24.99% | 6.89% | 1.81% | 5.31% | 16.66% | 18.82% | 18.22% | -12.61% | 10.60% | 13.90% | -34.36% | -38.38% | -38.01% | -24.22% | -28.71% | 18.37% | 24.20% | 19.50% | 28.19% | 13.85% | 15.19% | 20.94% |
Operating Income | -8.54B | -40.14B | -14.14B | -13.84B | 10.08B | 9.31B | 9.43B | 12.49B | 12.63B | 6.06B | 1.58B | 4.23B | 4.17B | 5.70B | 1.82B | -15.08B | 38.54M | -2.99B | 14.25M | 1.48B | 221.46M | 1.06B | 874.67M | -158.35M | -421.59M | -681.70M | 520.49M | 463.31M | 674.23M | 560.30M |
Operating Income Ratio | -7.51% | -87.06% | -21.14% | -23.67% | 8.35% | 8.08% | 9.20% | 12.62% | 13.44% | 6.72% | 1.79% | 4.96% | 5.00% | 7.65% | 4.52% | -36.13% | 0.09% | -7.98% | 0.05% | 7.03% | 1.55% | 8.13% | 7.20% | -1.41% | -4.15% | -8.34% | 6.09% | 6.27% | 10.18% | 9.23% |
Total Other Income/Expenses | 266.00M | -10.00M | 275.00M | 320.00M | -6.06B | -5.65B | -1.06B | -6.17B | 5.30B | 4.39B | 3.20B | 1.26B | 869.79M | 68.92M | 1.61B | 767.51M | 212.44M | -624.26M | -578.35M | -633.77M | -631.59M | -801.16M | -726.02M | 261.58M | 654.41M | 957.62K | 6.21M | 341.08K | -233.90K | 84.30M |
Income Before Tax | -8.28B | -40.15B | -17.51B | -16.49B | 4.30B | 3.86B | 8.61B | 6.50B | 5.67B | 4.11B | 2.22B | 3.01B | 4.84B | 5.42B | 249.21M | -15.26B | 268.27M | -3.62B | -577.43M | 845.41M | -589.83M | 262.89M | 313.58M | 275.23M | 210.56M | -558.90M | 924.05M | 463.65M | 674.00M | 644.60M |
Income Before Tax Ratio | -7.28% | -87.08% | -26.18% | -28.20% | 3.56% | 3.35% | 8.40% | 6.57% | 6.03% | 4.56% | 2.51% | 3.53% | 5.80% | 7.28% | 0.62% | -36.55% | 0.63% | -9.64% | -2.10% | 4.02% | -4.13% | 2.01% | 2.58% | 2.45% | 2.07% | -6.84% | 10.82% | 6.27% | 10.18% | 10.62% |
Income Tax Expense | 336.00M | -254.00M | -4.23B | -3.93B | 819.00M | 926.00M | 1.80B | 1.54B | 624.00M | 573.00M | 124.28M | 204.80M | 264.23M | 133.49M | 52.55M | 73.92M | 23.76M | -162.93M | -138.70M | 181.22M | 247.55M | 54.44M | -261.45M | 99.66M | 59.92M | -77.83M | 291.46M | 141.58M | 217.56M | 220.98M |
Net Income | -8.23B | -37.39B | -13.28B | -12.56B | 3.19B | 2.70B | 6.34B | 4.50B | 4.54B | 3.41B | 2.37B | 2.95B | 4.58B | 4.96B | 168.77M | -15.27B | 244.50M | -3.45B | -438.73M | 514.08M | -949.82M | 86.37M | 541.71M | 175.57M | 150.64M | -481.07M | 632.59M | 319.00M | 461.08M | 444.98M |
Net Income Ratio | -7.23% | -81.08% | -19.86% | -21.48% | 2.64% | 2.34% | 6.19% | 4.55% | 4.83% | 3.78% | 2.69% | 3.46% | 5.48% | 6.66% | 0.42% | -36.58% | 0.58% | -9.21% | -1.60% | 2.44% | -6.65% | 0.66% | 4.46% | 1.56% | 1.48% | -5.89% | 7.40% | 4.32% | 6.96% | 7.33% |
EPS | -0.37 | -1.98 | -0.79 | -0.77 | 0.21 | 0.19 | 0.44 | 0.33 | 0.36 | 0.27 | 0.20 | 0.28 | 0.43 | 0.48 | 0.11 | -3.14 | 0.12 | -0.70 | -0.09 | 0.11 | -0.20 | 0.03 | 0.02 | 0.00 | 0.04 | -0.10 | 0.07 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.37 | -1.98 | -0.79 | -0.77 | 0.21 | 0.19 | 0.44 | 0.33 | 0.36 | 0.27 | 0.20 | 0.28 | 0.43 | 0.48 | 0.11 | -3.14 | 0.12 | -0.70 | -0.09 | 0.11 | -0.19 | 0.03 | 0.02 | 0.00 | 0.04 | -0.10 | 0.07 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 22.29B | 18.87B | 16.80B | 16.38B | 15.10B | 14.26B | 14.44B | 13.66B | 12.61B | 12.66B | 11.79B | 11.33B | 11.36B | 11.21B | 6.43B | 4.87B | 5.03B | 4.90B | 4.67B | 4.58B | 4.77B | 5.19B | 5.06B | 4.88B | 4.87B | 4.84B | 3.82B | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 22.29B | 18.87B | 16.80B | 16.38B | 15.10B | 14.26B | 14.44B | 13.66B | 12.61B | 12.66B | 11.79B | 11.33B | 11.36B | 11.21B | 6.43B | 4.87B | 5.03B | 4.90B | 4.67B | 4.76B | 4.88B | 5.19B | 5.06B | 4.98B | 4.87B | 4.84B | 3.82B | 0.00 | 0.00 | 0.00 |
CEA Industries Inc. Negotiating to Acquire a Leading Specialty Retailer
CEA Industries Inc. Reports Third Quarter 2024 Results
A2 Bio to Highlight Progress of CAR T Clinical Programs in Three Poster Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
‘Lineman Diwas’ – A Unique Initiative by the Central Electricity Authority to Honor the Selfless Contribution of Frontline Workforce of the Power Sector
Qantas, China Eastern Airlines withdraw request to regulator to extend pact
China Eastern Airlines just made the biggest C919 order ever, for 100 planes
China Eastern Airlines Join 2023 North Bund International Aviation Forum
China Eastern Airlines Opens Direct Flights Between Shanghai and Istanbul on September 28
What Does the Debt Ceiling Mean for the Stock Market?
China Eastern Airlines shines at China Brand Day events
Source: https://incomestatements.info
Category: Stock Reports